Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 8

Advertisement Just one of many high quality articles Frontiers in Genetics has to offer:  BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention In this article from Frontiers in Genetics, Sergio Stagnaro and Simone Caramel suggest an original clinical tool for the diagnosis of Inherited Real Risk (IRR) of breast cancer which can support the current sophisticated ways for breast cancer risk assessment. TABLE OF CONTENTS Volume 20, Issue 8 (August 2013) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Gene Therapy celebrates a rising Impact Factor - 4.321* Make an impact when you submit your paper to Gene Therapy. Benefit from: - High exposure through Nature.com  - Competitive turnaround times - Open access option - Inclusion in the leading abstracting and indexing services  Submit your research today. *2012 Journal Citation Reports® (Thomson Reuters, 2013)   Original Articles Top Development of a novel adenovirus–alphavirus hybrid vector with RNA replicon features for malignant hematopoietic cell transduction Y Yang, F Xiao, Z Lu, Z Li, H Zuo, Q Zhang, Q Li, H Wang and L-S Wang Cancer Gene Ther 2013 20: 429-436; advance online publication, July 5, 2013; 10.1038/cgt.2013.37 Abstract | Full Text The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus K Fujii, K Kurozumi, T Ichikawa, M Onishi, Y Shimazu, J Ishida, E A Chiocca, B Kaur and I Date Cancer Gene Ther 2013 20: 437-444; advance online publication, July 5, 2013; 10.1038/cgt.2013.38 Abstract | Full Text Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor M S Beatty and D T Curiel Cancer Gene Ther 2013 20: 445-452; advance online publication, August 9, 2013; 10.1038/cgt.2013.39 Abstract | Full Text Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo C M Xu, W W Liu, C J Liu, C Wen, H F Lu and F S Wan Cancer Gene Ther 2013 20: 453-460; advance online publication, August 9, 2013; 10.1038/cgt.2013.40 Abstract | Full Text Combining virotherapy and angiotherapy for the treatment of breast cancer M Bazan-Peregrino, R C A Sainson, R C Carlisle, C Thoma, R A Waters, C Arvanitis, A L Harris, R Hernandez-Alcoceba and L W Seymour Cancer Gene Ther 2013 20: 461-468; advance online publication, July 12, 2013; 10.1038/cgt.2013.41 Abstract | Full Text Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells L Chen, J L Taylor, N C Sabins, D B Lowe, Y Qu, Z You and W J Storkus Cancer Gene Ther 2013 20: 469-477; advance online publication, July 12, 2013; 10.1038/cgt.2013.42 Abstract | Full Text HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy Open H Li, H Nakashima, T D Decklever, R A Nace and S J Russell Cancer Gene Ther 2013 20: 478-485; advance online publication, July 19, 2013; 10.1038/cgt.2013.43 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.